Jonathan E. Lim

Companies

• Maze Therapeutics, Inc.Board member Jan 30, 2025 to now¹
• Boundless Bio (United States)Board member Mar 27, 2024 to now²
• Erasca, Inc.Chief executive officer Feb 3, 2022 to now³
• Erasca, Inc.Chair Feb 3, 2022 to now³
• Erasca, Inc.Board member Jul 15, 2021 to Jul 20, 2021⁴
• Erasca, Inc.Officer Jul 15, 2021 to Jul 20, 2021⁴
• Halozyme TherapeuticsBoard member Feb 7, 2007 to Feb 8, 2010⁵
• Halozyme TherapeuticsChief executive officer Feb 7, 2007 to Feb 8, 2010⁵
• Halozyme TherapeuticsPresident Feb 7, 2007 to Feb 9, 2009⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• EErasca, Inc. ERAS19,456,216 shares⁶$291.8M at $15.00Dec 6, 2023
• MTMaze Therapeutics, Inc. MAZE328,700 shares⁷$9.0M at $27.48Feb 4, 2025
• BBBoundless Bio (United States) BOLD653,479 shares⁸$1.5M at $2.34Apr 4, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 3, 2025Converted 270,232 shares of Maze Therapeutics, Inc.⁷
• Feb 3, 2025Converted 37,724 shares of Maze Therapeutics, Inc.⁷
• Apr 2, 2024Converted 525,274 shares of Boundless Bio (United States)⁸
• Dec 6, 2023Bought 278,150 shares at $1.72 of Erasca, Inc.⁶
• Dec 5, 2023Bought 721,850 shares at $1.69 of Erasca, Inc.⁶
• Oct 5, 2023Bought 1,000,000 shares at $2.03 of Erasca, Inc.⁹
• Jun 8, 2023Bought 100,000 shares at $2.75 of Erasca, Inc.¹⁰
• Mar 28, 2023Bought 100,000 shares at $2.84 of Erasca, Inc.¹¹
• Jan 10, 2023Bought 60,000 shares at $3.86 of Erasca, Inc.¹²
• Dec 14, 2022Bought 40,000 shares at $4.99 of Erasca, Inc.¹³
• Nov 30, 2022Gift 2,000,006 shares of Erasca, Inc.¹⁴